121 related articles for article (PubMed ID: 7271910)
1. Effect of hyperprolactinaemia due to pituitary tumour on serum albumin, protein and oncotic pressure.
Brajkovich IE; De Leon RS; Mashiter K
Clin Sci (Lond); 1981 Jul; 61(1):119-21. PubMed ID: 7271910
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin.
Miyai K; Ichihara K; Kondo K; Mori S
Clin Endocrinol (Oxf); 1986 Nov; 25(5):549-54. PubMed ID: 3621622
[TBL] [Abstract][Full Text] [Related]
3. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
[TBL] [Abstract][Full Text] [Related]
4. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced hyperprolactinaemia in a treated acromegalic.
Shalet SM; MacFarlane IA; Beardwell CG
Clin Endocrinol (Oxf); 1979; 11(2):169-71. PubMed ID: 487615
[TBL] [Abstract][Full Text] [Related]
6. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
[TBL] [Abstract][Full Text] [Related]
8. Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment.
Franks S; Nabarro JD
Ann Clin Res; 1978; 10(3):157-63. PubMed ID: 718118
[TBL] [Abstract][Full Text] [Related]
9. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
[TBL] [Abstract][Full Text] [Related]
10. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
Smith CR; Butler J; Hashim I; Norman MR
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
[TBL] [Abstract][Full Text] [Related]
11. Effect of dopamine infusion on serum prolactin concentration in normal and hyperprolactinaemic subjects.
Reschini E; Ferrari C; Peracchi M; Fadini R; Meschia M; Crosignani PG
Clin Endocrinol (Oxf); 1980 Dec; 13(6):519-23. PubMed ID: 7226569
[TBL] [Abstract][Full Text] [Related]
12. Depot-bromocriptine treatment for prolactinomas and acromegaly.
Grossman A; Ross R; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
[TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine on serum prolactin in normal women and patients with hyperprolactinaemia.
Carlson HE; Chang RJ; Meyer NV; Lu KH; Judd HL
Clin Endocrinol (Oxf); 1981 Nov; 15(5):491-8. PubMed ID: 6799231
[TBL] [Abstract][Full Text] [Related]
14. Cardiomegaly and heart failure in a patient with prolactin-secreting pituitary tumour.
Curtarelli G; Ferrari C
Thorax; 1979 Jun; 34(3):328-31. PubMed ID: 158231
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous development of hyperprolactinaemia.
Rjosk HK; Fahlbusch R; von Werder K
Acta Endocrinol (Copenh); 1982 Jul; 100(3):333-6. PubMed ID: 7113601
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.
Franks S; Nabarro JD
Lancet; 1977 Apr; 1(8015):778-80. PubMed ID: 66572
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas.
Serri O; Somma M; Rasio E; Brazeau P
Clin Endocrinol (Oxf); 1989 Jan; 30(1):65-75. PubMed ID: 2505955
[TBL] [Abstract][Full Text] [Related]
18. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.
Pontiroli AE; Falsetti L
Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360
[TBL] [Abstract][Full Text] [Related]
19. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
20. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
